ANC 0 3 0 3 B-clinical_variable
> 4 5 4 5 O
750 6 9 6 9 B-lower_bound
/ 9 10 9 10 I-lower_bound
microL 10 16 10 16 I-lower_bound

Active 0 6 17 23 O
Hepatitis 7 16 24 33 B-chronic_disease
B 17 18 34 35 I-chronic_disease
or 19 21 36 38 O
Hepatitis 22 31 39 48 B-chronic_disease
C 32 33 49 50 I-chronic_disease
infection 34 43 51 60 I-chronic_disease

Active 0 6 61 67 O
autoimmune 7 17 68 78 B-chronic_disease
hemolytic 18 27 79 88 I-chronic_disease
anemia 28 34 89 95 I-chronic_disease
or 35 37 96 98 O
thrombocytopenia 38 54 99 115 B-chronic_disease

Active 0 6 116 122 B-chronic_disease
disease 7 14 123 130 I-chronic_disease
as 15 17 131 133 O
defined 18 25 134 141 O
by 26 28 142 144 O
at 29 31 145 147 O
least 32 37 148 153 O
one 38 41 154 157 B-lower_bound
of 42 44 158 160 O
the 45 48 161 164 O
following 49 58 165 174 O
( 59 60 175 176 O
IWCLL 60 65 176 181 O
consensus 66 75 182 191 O
criteria 76 84 192 200 O
) 84 85 200 201 O

CLL 0 3 202 205 B-clinical_variable
: 3 4 205 206 O
clonal 5 11 207 213 B-clinical_variable
B 12 13 214 215 I-clinical_variable
- 13 14 215 216 I-clinical_variable
lymphocytosis 14 27 216 229 I-clinical_variable
greater 28 35 230 237 O
than 36 40 238 242 O
or 41 43 243 245 O
equal 44 49 246 251 O
to 50 52 252 254 O
5,000 53 58 255 260 B-lower_bound
cells 59 64 261 266 I-lower_bound
/ 64 65 266 267 I-lower_bound
microL 65 71 267 273 I-lower_bound

Concomitant 0 11 274 285 B-treatment
immunomodulatory 12 28 286 302 I-treatment
therapy 29 36 303 310 I-treatment
, 36 37 310 311 O
chemotherapy 38 50 312 324 B-treatment
, 50 51 324 325 O
radiotherapy 52 64 326 338 B-treatment
or 65 67 339 341 O
experimental 68 80 342 354 B-treatment
therapy 81 88 355 362 I-treatment

Currently 0 9 363 372 O
active 10 16 373 379 O
, 16 17 379 380 O
clinically 18 28 381 391 O
significant 29 40 392 403 O
cardiovascular 41 55 404 418 B-chronic_disease
disease 56 63 419 426 I-chronic_disease
such 64 68 427 431 O
as 69 71 432 434 O
uncontrolled 72 84 435 447 O
or 85 87 448 450 O
symptomatic 88 99 451 462 O
arrhythmias 100 111 463 474 B-chronic_disease
, 111 112 474 475 O
Class 113 118 476 481 B-chronic_disease
3 119 120 482 483 I-chronic_disease
or 121 123 484 486 I-chronic_disease
4 124 125 487 488 I-chronic_disease
congestive 126 136 489 499 I-chronic_disease
heart 137 142 500 505 I-chronic_disease
failure 143 150 506 513 I-chronic_disease
as 151 153 514 516 O
defined 154 161 517 524 O
by 162 164 525 527 O
New 165 168 528 531 O
York 169 173 532 536 O
Heart 174 179 537 542 O
Association 180 191 543 554 O
Functional 192 202 555 565 O
Classification 203 217 566 580 O
, 217 218 580 581 O
or 219 221 582 584 O
a 222 223 585 586 O
history 224 231 587 594 O
of 232 234 595 597 O
myocardial 235 245 598 608 B-chronic_disease
infarction 246 256 609 619 I-chronic_disease
or 257 259 620 622 O
unstable 260 268 623 631 B-chronic_disease
angina 269 275 632 638 I-chronic_disease
, 275 276 638 639 O
or 277 279 640 642 O
acute 280 285 643 648 B-chronic_disease
coronary 286 294 649 657 I-chronic_disease
syndrome 295 303 658 666 I-chronic_disease
within 304 310 667 673 O
6 311 312 674 675 B-upper_bound
months 313 319 676 682 I-upper_bound
of 320 322 683 685 O
screening 323 332 686 695 O

Eastern 0 7 696 703 B-clinical_variable
Cooperative 8 19 704 715 I-clinical_variable
Oncology 20 28 716 724 I-clinical_variable
Group 29 34 725 730 I-clinical_variable
( 35 36 731 732 I-clinical_variable
ECOG 36 40 732 736 I-clinical_variable
) 40 41 736 737 I-clinical_variable
performance 42 53 738 749 I-clinical_variable
status 54 60 750 756 I-clinical_variable
of 61 63 757 759 O
less 64 68 760 764 O
than 69 73 765 769 O
or 74 76 770 772 O
equal 77 82 773 778 O
to 83 85 779 781 O
2 86 87 782 783 B-upper_bound

Evidence 0 8 784 792 O
of 9 11 793 795 O
progressive 12 23 796 807 O
marrow 24 30 808 814 B-chronic_disease
failure 31 38 815 822 I-chronic_disease
as 39 41 823 825 O
manifested 42 52 826 836 O
by 53 55 837 839 O
the 56 59 840 843 O
development 60 71 844 855 O
of 72 74 856 858 O
, 74 75 858 859 O
or 76 78 860 862 O
worsening 79 88 863 872 O
of 89 91 873 875 O
, 91 92 875 876 O
anemia 93 99 877 883 B-chronic_disease
and/or 100 106 884 890 O
thrombocytopenia 107 123 891 907 B-chronic_disease

Extreme 0 7 908 915 B-chronic_disease
fatigue 8 15 916 923 I-chronic_disease

Female 0 6 924 930 B-gender
patients 7 15 931 939 I-gender
who 16 19 940 943 O
are 20 23 944 947 O
currently 24 33 948 957 B-pregnancy
in 34 36 958 960 I-pregnancy
pregnancy 37 46 961 970 I-pregnancy
, 46 47 970 971 O
or 48 50 972 974 O
unwilling 51 60 975 984 B-contraception_consent
to 61 63 985 987 I-contraception_consent
use 64 67 988 991 I-contraception_consent
acceptable 68 78 992 1002 I-contraception_consent
methods 79 86 1003 1010 I-contraception_consent
of 87 89 1011 1013 I-contraception_consent
contraception 90 103 1014 1027 I-contraception_consent
or 104 106 1028 1030 O
refrain 107 114 1031 1038 O
from 115 119 1039 1043 O
pregnancy 120 129 1044 1053 O
if 130 132 1054 1056 O
of 133 135 1057 1059 O
childbearing 136 148 1060 1072 O
potential 149 158 1073 1082 O
or 159 161 1083 1085 O
currently 162 171 1086 1095 O
breastfeeding 172 185 1096 1109 O

Female 0 6 1110 1116 B-gender
subjects 7 15 1117 1125 I-gender
of 16 18 1126 1128 O
childbearing 19 31 1129 1141 O
potential 32 41 1142 1151 O
must 42 46 1152 1156 O
have 47 51 1157 1161 O
a 52 53 1162 1163 O
negative 54 62 1164 1172 B-pregnancy
serum 63 68 1173 1178 I-pregnancy
pregnancy 69 78 1179 1188 I-pregnancy
test 79 83 1189 1193 O
upon 84 88 1194 1198 O
study 89 94 1199 1204 O
entry 95 100 1205 1210 O

Female 0 6 1211 1217 B-gender
subjects 7 15 1218 1226 I-gender
who 16 19 1227 1230 O
are 20 23 1231 1234 O
of 24 26 1235 1237 O
non 27 30 1238 1241 O
- 30 31 1241 1242 O
reproductive 31 43 1242 1254 O
potential 44 53 1255 1264 O
( 54 55 1265 1266 O
ie 55 57 1266 1268 O
, 57 58 1268 1269 O
post 59 63 1270 1274 O
- 63 64 1274 1275 O
menopausal 64 74 1275 1285 O
by 75 77 1286 1288 O
history 78 85 1289 1296 O
no 86 88 1297 1299 O
menses 89 95 1300 1306 O
for 96 99 1307 1310 O
greater 100 107 1311 1318 O
than 108 112 1319 1323 O
or 113 115 1324 1326 O
equal 116 121 1327 1332 O
to 122 124 1333 1335 O
1 125 126 1336 1337 B-lower_bound
year 127 131 1338 1342 I-lower_bound

Fevers 0 6 1343 1349 O
of 7 9 1350 1352 O
greater 10 17 1353 1360 O
than 18 22 1361 1365 O
100.5 23 28 1366 1371 B-lower_bound
F 29 30 1372 1373 I-lower_bound
for 31 34 1374 1377 O
greater 35 42 1378 1385 O
than 43 47 1386 1390 O
or 48 50 1391 1393 O
equal 51 56 1394 1399 O
to 57 59 1400 1402 O
2 60 61 1403 1404 B-lower_bound
weeks 62 67 1405 1410 I-lower_bound
without 68 75 1411 1418 O
evidence 76 84 1419 1427 O
of 85 87 1428 1430 O
infection 88 97 1431 1440 B-chronic_disease

HIV 0 3 1441 1444 B-chronic_disease
infection 4 13 1445 1454 I-chronic_disease

History 0 7 1455 1462 O
of 8 10 1463 1465 O
stroke 11 17 1466 1472 B-chronic_disease
or 18 20 1473 1475 O
intracranial 21 33 1476 1488 B-chronic_disease
hemorrhage 34 44 1489 1499 I-chronic_disease
within 45 51 1500 1506 O
6 52 53 1507 1508 B-upper_bound
months 54 60 1509 1515 I-upper_bound
before 61 67 1516 1522 I-upper_bound
the 68 71 1523 1526 O
first 72 77 1527 1532 O
dose 78 82 1533 1537 O
of 83 85 1538 1540 O
study 86 91 1541 1546 B-treatment
drug 92 96 1547 1551 I-treatment

Immunophenotypic 0 16 1552 1568 B-treatment
profile 17 24 1569 1576 O
or 25 27 1577 1579 O
immunohistochemistry 28 48 1580 1600 B-treatment
read 49 53 1601 1605 O
by 54 56 1606 1608 O
an 57 59 1609 1611 O
expert 60 66 1612 1618 O
pathologist 67 78 1619 1630 O
as 79 81 1631 1633 O
consistent 82 92 1634 1644 O
with 93 97 1645 1649 O
CLL 98 101 1650 1653 B-cancer

Impaired 0 8 1654 1662 O
hepatic 9 16 1663 1670 B-chronic_disease
function 17 25 1671 1679 I-chronic_disease

Impaired 0 8 1680 1688 B-chronic_disease
renal 9 14 1689 1694 I-chronic_disease
function 15 23 1695 1703 I-chronic_disease

Individuals 0 11 1704 1715 O
< 12 13 1716 1717 O
18 14 16 1718 1720 B-upper_bound
years 17 22 1721 1726 I-upper_bound
old 23 26 1727 1730 O

Known 0 5 1731 1736 O
bleeding 6 14 1737 1745 B-chronic_disease
disorders 15 24 1746 1755 I-chronic_disease

Known 0 5 1756 1761 O
hypersensitivity 6 22 1762 1778 O
to 23 25 1779 1781 O
any 26 29 1782 1785 O
component 30 39 1786 1795 O
of 40 42 1796 1798 O
ibrutinib 43 52 1799 1808 B-allergy_name
or 53 55 1809 1811 O
fludarabine 56 67 1812 1823 B-allergy_name

Life 0 4 1824 1828 B-chronic_disease
- 4 5 1828 1829 I-chronic_disease
threatening 5 16 1829 1840 I-chronic_disease
illness 17 24 1841 1848 I-chronic_disease
, 24 25 1848 1849 O
medical 26 33 1850 1857 B-chronic_disease
condition 34 43 1858 1867 I-chronic_disease
or 44 46 1868 1870 O
organ 47 52 1871 1876 B-chronic_disease
system 53 59 1877 1883 I-chronic_disease
dysfunction 60 71 1884 1895 I-chronic_disease
which 72 77 1896 1901 O
, 77 78 1901 1902 O
in 79 81 1903 1905 O
the 82 85 1906 1909 O
investigator 86 98 1910 1922 O
s 99 100 1923 1924 O
opinion 101 108 1925 1932 O
, 108 109 1932 1933 O
could 110 115 1934 1939 O
compromise 116 126 1940 1950 O
the 127 130 1951 1954 O
subject 131 138 1955 1962 O
s 139 140 1963 1964 O
safety 141 147 1965 1971 O
, 147 148 1971 1972 O
interfere 149 158 1973 1982 O
with 159 163 1983 1987 O
the 164 167 1988 1991 O
absorption 168 178 1992 2002 O
or 179 181 2003 2005 O
metabolism 182 192 2006 2016 O
of 193 195 2017 2019 O
ibrutinib 196 205 2020 2029 B-treatment
and 206 209 2030 2033 O
fludarabine 210 221 2034 2045 B-treatment
, 221 222 2045 2046 O
or 223 225 2047 2049 O
put 226 229 2050 2053 O
the 230 233 2054 2057 O
study 234 239 2058 2063 O
outcomes 240 248 2064 2072 O
at 249 251 2073 2075 O
undue 252 257 2076 2081 O
risk 258 262 2082 2086 O

Major 0 5 2087 2092 B-treatment
surgery 6 13 2093 2100 I-treatment
within 14 20 2101 2107 O
4 21 22 2108 2109 B-upper_bound
weeks 23 28 2110 2115 I-upper_bound
of 29 31 2116 2118 O
first 32 37 2119 2124 O
dose 38 42 2125 2129 O
of 43 45 2130 2132 O
study 46 51 2133 2138 B-treatment
drug 52 56 2139 2143 I-treatment

Malabsorption 0 13 2144 2157 B-chronic_disease
syndrome 14 22 2158 2166 I-chronic_disease
, 22 23 2166 2167 O
disease 24 31 2168 2175 O
significantly 32 45 2176 2189 O
affecting 46 55 2190 2199 O
gastrointestinal 56 72 2200 2216 B-chronic_disease
function 73 81 2217 2225 I-chronic_disease
, 81 82 2225 2226 O
or 83 85 2227 2229 O
resection 86 95 2230 2239 B-chronic_disease
of 96 98 2240 2242 I-chronic_disease
the 99 102 2243 2246 I-chronic_disease
stomach 103 110 2247 2254 I-chronic_disease
or 111 113 2255 2257 I-chronic_disease
small 114 119 2258 2263 I-chronic_disease
bowel 120 125 2264 2269 I-chronic_disease
or 126 128 2270 2272 I-chronic_disease
ulcerative 129 139 2273 2283 I-chronic_disease
colitis 140 147 2284 2291 I-chronic_disease
, 147 148 2291 2292 O
symptomatic 149 160 2293 2304 B-chronic_disease
inflammatory 161 173 2305 2317 I-chronic_disease
bowel 174 179 2318 2323 I-chronic_disease
disease 180 187 2324 2331 I-chronic_disease
, 187 188 2331 2332 O
or 189 191 2333 2335 O
partial 192 199 2336 2343 B-chronic_disease
or 200 202 2344 2346 I-chronic_disease
complete 203 211 2347 2355 I-chronic_disease
bowel 212 217 2356 2361 I-chronic_disease
obstruction 218 229 2362 2373 I-chronic_disease

Male 0 4 2374 2378 B-gender
and 5 8 2379 2382 O
female 9 15 2383 2389 B-gender
subjects 16 24 2390 2398 I-gender
who 25 28 2399 2402 O
agree 29 34 2403 2408 B-contraception_consent
to 35 37 2409 2411 I-contraception_consent
use 38 41 2412 2415 I-contraception_consent
both 42 46 2416 2420 I-contraception_consent
a 47 48 2421 2422 I-contraception_consent
highly 49 55 2423 2429 I-contraception_consent
effective 56 65 2430 2439 I-contraception_consent
method 66 72 2440 2446 I-contraception_consent
of 73 75 2447 2449 I-contraception_consent
birth 76 81 2450 2455 I-contraception_consent
control 82 89 2456 2463 I-contraception_consent
( 90 91 2464 2465 O
eg 91 93 2465 2467 O
, 93 94 2467 2468 O
implants 95 103 2469 2477 B-contraception_consent
, 103 104 2477 2478 O
injectables 105 116 2479 2490 B-contraception_consent
, 116 117 2490 2491 O
combined 118 126 2492 2500 B-contraception_consent
oral 127 131 2501 2505 I-contraception_consent
contraceptives 132 146 2506 2520 I-contraception_consent
, 146 147 2520 2521 O
some 148 152 2522 2526 O
intrauterine 153 165 2527 2539 B-contraception_consent
devices 166 173 2540 2547 I-contraception_consent
, 173 174 2547 2548 O
complete 175 183 2549 2557 B-contraception_consent
abstinence 184 194 2558 2568 I-contraception_consent
, 194 195 2568 2569 O
or 196 198 2570 2572 O
sterilized 199 209 2573 2583 B-contraception_consent
partner 210 217 2584 2591 I-contraception_consent
) 217 218 2591 2592 O
and 219 222 2593 2596 O
a 223 224 2597 2598 O
barrier 225 232 2599 2606 B-contraception_consent
method 233 239 2607 2613 I-contraception_consent
( 240 241 2614 2615 O
e.g. 241 245 2615 2619 O
condoms 246 253 2620 2627 B-contraception_consent
, 253 254 2627 2628 O
vaginal 255 262 2629 2636 B-contraception_consent
ring 263 267 2637 2641 I-contraception_consent
, 267 268 2641 2642 O
sponge 269 275 2643 2649 B-contraception_consent
, 275 276 2649 2650 O
etc 277 280 2651 2654 O
. 280 281 2654 2655 O
) 281 282 2655 2656 O
during 283 289 2657 2663 O
the 290 293 2664 2667 O
period 294 300 2668 2674 O
of 301 303 2675 2677 O
therapy 304 311 2678 2685 B-treatment
and 312 315 2686 2689 O
for 316 319 2690 2693 O
90 320 322 2694 2696 B-lower_bound
days 323 327 2697 2701 I-lower_bound
after 328 333 2702 2707 I-lower_bound
the 334 337 2708 2711 O
last 338 342 2712 2716 O
dose 343 347 2717 2721 O
of 348 350 2722 2724 O
study 351 356 2725 2730 O
drug 357 361 2731 2735 O

Male 0 4 2736 2740 B-gender
patients 5 13 2741 2749 I-gender
who 14 17 2750 2753 O
are 18 21 2754 2757 O
unwilling 22 31 2758 2767 B-contraception_consent
to 32 34 2768 2770 I-contraception_consent
follow 35 41 2771 2777 I-contraception_consent
the 42 45 2778 2781 I-contraception_consent
contraception 46 59 2782 2795 I-contraception_consent
requirements 60 72 2796 2808 O
described 73 82 2809 2818 O
in 83 85 2819 2821 O
this 86 90 2822 2826 O
protocol 91 99 2827 2835 O

Massive 0 7 2836 2843 O
nodes 8 13 2844 2849 O
or 14 16 2850 2852 O
clusters 17 25 2853 2861 O
or 26 28 2862 2864 O
progressive 29 40 2865 2876 O
lymphadenopathy 41 56 2877 2892 B-chronic_disease

Massive 0 7 2893 2900 B-chronic_disease
or 8 10 2901 2903 O
progressive 11 22 2904 2915 B-chronic_disease
splenomegaly 23 35 2916 2928 I-chronic_disease

Men 0 3 2929 2932 B-gender
and 4 7 2933 2936 O
women 8 13 2937 2942 B-gender
with 14 18 2943 2947 O
histologically 19 33 2948 2962 O
confirmed 34 43 2963 2972 O
disease 44 51 2973 2980 O

Night 0 5 2981 2986 O
sweats 6 12 2987 2993 O
for 13 16 2994 2997 O
more 17 21 2998 3002 O
than 22 26 3003 3007 O
one 27 30 3008 3011 B-lower_bound
month 31 36 3012 3017 I-lower_bound
without 37 44 3018 3025 O
evidence 45 53 3026 3034 O
of 54 56 3035 3037 O
infection 57 66 3038 3047 B-chronic_disease

Prior 0 5 3048 3053 O
malignancy 6 16 3054 3064 B-cancer

Progressive 0 11 3065 3076 O
lymphocytosis 12 25 3077 3090 O
with 26 30 3091 3095 O
an 31 33 3096 3098 O
increase 34 42 3099 3107 O
of 43 45 3108 3110 O
> 46 47 3111 3112 O
50 47 49 3112 3114 B-lower_bound
% 49 50 3114 3115 I-lower_bound
over 51 55 3116 3120 O
a 56 57 3121 3122 O
2 58 59 3123 3124 B-lower_bound
- 59 60 3124 3125 I-lower_bound
month 60 65 3125 3130 I-lower_bound
period 66 72 3131 3137 I-lower_bound
, 72 73 3137 3138 O
or 74 76 3139 3141 O
an 77 79 3142 3144 O
anticipated 80 91 3145 3156 O
doubling 92 100 3157 3165 O
time 101 105 3166 3170 O
of 106 108 3171 3173 O
less 109 113 3174 3178 O
than 114 118 3179 3183 O
6 119 120 3184 3185 B-upper_bound
months 121 127 3186 3192 I-upper_bound

Psychiatric 0 11 3193 3204 B-chronic_disease
illness 12 19 3205 3212 I-chronic_disease
/ 19 20 3212 3213 I-chronic_disease
social 20 26 3213 3219 I-chronic_disease
situations 27 37 3220 3230 I-chronic_disease
that 38 42 3231 3235 O
would 43 48 3236 3241 O
limit 49 54 3242 3247 O
the 55 58 3248 3251 O
patient 59 66 3252 3259 O
s 67 68 3260 3261 O
ability 69 76 3262 3269 O
to 77 79 3270 3272 O
tolerate 80 88 3273 3281 O
and/or 89 95 3282 3288 O
comply 96 102 3289 3295 O
with 103 107 3296 3300 O
study 108 113 3301 3306 O
requirements 114 126 3307 3319 O

Requires 0 8 3320 3328 O
concomitant 9 20 3329 3340 O
anticoagulation 21 36 3341 3356 B-treatment
with 37 41 3357 3361 O
Coumadin 42 50 3362 3370 B-treatment
( 51 52 3371 3372 I-treatment
warfarin 52 60 3372 3380 I-treatment
) 60 61 3380 3381 I-treatment
or 62 64 3382 3384 O
other 65 70 3385 3390 O
vitamin 71 78 3391 3398 B-treatment
K 79 80 3399 3400 I-treatment
antagonists 81 92 3401 3412 I-treatment

SLL 0 3 3413 3416 B-cancer
: 3 4 3416 3417 O
lymphadenopathy 5 20 3418 3433 B-chronic_disease
with 21 25 3434 3438 O
the 26 29 3439 3442 O
tissue 30 36 3443 3449 O
morphology 37 47 3450 3460 O
of 48 50 3461 3463 O
CLL 51 54 3464 3467 B-cancer
but 55 58 3468 3471 O
that 59 63 3472 3476 O
are 64 67 3477 3480 O
not 68 71 3481 3484 O
leukemic 72 80 3485 3493 O
, 80 81 3493 3494 O
< 82 83 3495 3496 O
5,000 84 89 3497 3502 B-upper_bound
cells 90 95 3503 3508 I-upper_bound
/ 95 96 3508 3509 I-upper_bound
microL 96 102 3509 3515 I-upper_bound

Subjects 0 8 3516 3524 O
who 9 12 3525 3528 O
received 13 21 3529 3537 O
a 22 23 3538 3539 O
strong 24 30 3540 3546 O
cytochrome 31 41 3547 3557 B-treatment
P450 42 46 3558 3562 I-treatment
( 47 48 3563 3564 I-treatment
CYP 48 51 3564 3567 I-treatment
) 51 52 3567 3568 I-treatment
3A 53 55 3569 3571 I-treatment
inhibitor 56 65 3572 3581 I-treatment
within 66 72 3582 3588 O
7 73 74 3589 3590 B-treatment
days 75 79 3591 3595 I-treatment
prior 80 85 3596 3601 I-treatment
to 86 88 3602 3604 O
the 89 92 3605 3608 O
first 93 98 3609 3614 O
dose 99 103 3615 3619 O
of 104 106 3620 3622 O
ibrutinib 107 116 3623 3632 B-treatment
or 117 119 3633 3635 O
subjects 120 128 3636 3644 O
who 129 132 3645 3648 O
require 133 140 3649 3656 O
continuous 141 151 3657 3667 O
treatment 152 161 3668 3677 B-treatment
with 162 166 3678 3682 O
a 167 168 3683 3684 O
strong 169 175 3685 3691 O
CYP3A 176 181 3692 3697 O
inhibitor 182 191 3698 3707 O

This 0 4 3708 3712 O
will 5 9 3713 3717 O
include 10 17 3718 3725 O
CD5 18 21 3726 3729 O
, 21 22 3729 3730 O
CD19 23 27 3731 3735 O
, 27 28 3735 3736 O
and 29 32 3737 3740 O
CD20 33 37 3741 3745 O
expression 38 48 3746 3756 O
by 49 51 3757 3759 O
the 52 55 3760 3763 O
CLL 56 59 3764 3767 B-cancer
cells 60 65 3768 3773 O
typically 66 75 3774 3783 O
also 76 80 3784 3788 O
with 81 85 3789 3793 O
CD23 86 90 3794 3798 O
expression 91 101 3799 3809 O
, 101 102 3809 3810 O
but 103 106 3811 3814 O
CD23 107 111 3815 3819 O
negative 112 120 3820 3828 O
cases 121 126 3829 3834 O
may 127 130 3835 3838 O
be 131 133 3839 3841 O
included 134 142 3842 3850 O
if 143 145 3851 3853 O
there 146 151 3854 3859 O
is 152 154 3860 3862 O
an 155 157 3863 3865 O
absence 158 165 3866 3873 O
of 166 168 3874 3876 O
t(11;14 169 176 3877 3884 O
) 176 177 3884 3885 O

Total 0 5 3886 3891 B-clinical_variable
bilirubin 6 15 3892 3901 I-clinical_variable
greater 16 23 3902 3909 O
than 24 28 3910 3914 O
or 29 31 3915 3917 O
equal 32 37 3918 3923 O
to 38 40 3924 3926 O
1.5 41 44 3927 3930 B-lower_bound
times 45 50 3931 3936 I-lower_bound
upper 51 56 3937 3942 I-lower_bound
limit 57 62 3943 3948 I-lower_bound
of 63 65 3949 3951 I-lower_bound
normal 66 72 3952 3958 I-lower_bound
unless 73 79 3959 3965 O
due 80 83 3966 3969 O
to 84 86 3970 3972 O
Gilbert 87 94 3973 3980 B-chronic_disease
s 95 96 3981 3982 I-chronic_disease
disease 97 104 3983 3990 I-chronic_disease

Transformed 0 11 3991 4002 B-cancer
CLL 12 15 4003 4006 I-cancer
, 15 16 4006 4007 O
including 17 26 4008 4017 O
Hodgkin 27 34 4018 4025 B-cancer
and 35 38 4026 4029 O
non 39 42 4030 4033 B-cancer
- 42 43 4033 4034 I-cancer
Hodgkin 43 50 4034 4041 I-cancer
lymphoma 51 59 4042 4050 I-cancer

Treatment 0 9 4051 4060 B-treatment
naive 10 15 4061 4066 O
CLL 16 19 4067 4070 B-cancer
/ 19 20 4070 4071 O
SLL 20 23 4071 4074 B-cancer
patients 24 32 4075 4083 O

Treatment 0 9 4084 4093 B-treatment
- 9 10 4093 4094 O
naive 10 15 4094 4099 O
CLL 16 19 4100 4103 B-cancer
indicates 20 29 4104 4113 O
no 30 32 4114 4116 O
prior 33 38 4117 4122 B-treatment
anti 39 43 4123 4127 I-treatment
- 43 44 4127 4128 I-treatment
CLL 44 47 4128 4131 I-treatment
therapy 48 55 4132 4139 I-treatment
. 55 56 4139 4140 O
Anti 57 61 4141 4145 B-treatment
- 61 62 4145 4146 I-treatment
CLL 62 65 4146 4149 I-treatment
therapy 66 73 4150 4157 I-treatment
includes 74 82 4158 4166 O
chemotherapies 83 97 4167 4181 B-treatment
, 97 98 4181 4182 O
monoclonal 99 109 4183 4193 B-treatment
antibodies 110 120 4194 4204 I-treatment
, 120 121 4204 4205 O
and 122 125 4206 4209 O
targeted 126 134 4210 4218 B-treatment
agents 135 141 4219 4225 I-treatment
with 142 146 4226 4230 I-treatment
known 147 152 4231 4236 I-treatment
or 153 155 4237 4239 I-treatment
reasonably 156 166 4240 4250 I-treatment
expected 167 175 4251 4259 I-treatment
anti 176 180 4260 4264 I-treatment
- 180 181 4264 4265 I-treatment
leukemic 181 189 4265 4273 I-treatment
activity 190 198 4274 4282 I-treatment

Weight 0 6 4283 4289 B-clinical_variable
loss 7 11 4290 4294 I-clinical_variable
greater 12 19 4295 4302 O
than 20 24 4303 4307 O
or 25 27 4308 4310 O
equal 28 33 4311 4316 O
to 34 36 4317 4319 O
10 37 39 4320 4322 B-lower_bound
% 39 40 4322 4323 I-lower_bound
within 41 47 4324 4330 O
the 48 51 4331 4334 O
previous 52 60 4335 4343 B-upper_bound
6 61 62 4344 4345 I-upper_bound
months 63 69 4346 4352 I-upper_bound

estimated 0 9 4353 4362 O
GFR 10 13 4363 4366 B-clinical_variable
< 14 15 4367 4368 O
30ml 16 20 4369 4373 B-upper_bound
/ 20 21 4373 4374 I-upper_bound
min/1.73m(2 21 32 4374 4385 I-upper_bound
) 32 33 4385 4386 I-upper_bound
based 34 39 4387 4392 O
on 40 42 4393 4395 O
CKD 43 46 4396 4399 O
- 46 47 4399 4400 O
EPI 47 50 4400 4403 O

history 0 7 4404 4411 O
of 8 10 4412 4414 O
bilateral 11 20 4415 4424 B-treatment
oophorectomy 21 33 4425 4437 I-treatment

history 0 7 4438 4445 O
of 8 10 4446 4448 O
bilateral 11 20 4449 4458 B-treatment
tubal 21 26 4459 4464 I-treatment
ligation 27 35 4465 4473 I-treatment

history 0 7 4474 4481 O
of 8 10 4482 4484 O
hysterectomy 11 23 4485 4497 B-treatment

platelets 0 9 4498 4507 B-clinical_variable
> 10 11 4508 4509 O
50,000 12 18 4510 4516 B-lower_bound
/ 18 19 4516 4517 I-lower_bound
microL 19 25 4517 4523 I-lower_bound

